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The response of the human acute myeloid leukemia cell line THP-1 to phorbol
esters has been widely studied to test candidate leukemia therapies and as a
model of cell cycle arrest and monocyte-macrophage differentiation. Here we have
employed Cap Analysis of Gene Expression (CAGE) to analyze a dense time course of
transcriptional regulation in THP-1 cells treated with phorbol myristate acetate (PMA)
over 96 h. PMA treatment greatly reduced the numbers of cells entering S phase
and also blocked cells exiting G2/M. The PMA-treated cells became adherent and
expression of mature macrophage-specific genes increased progressively over the
duration of the time course. Within 1–2 h PMA induced known targets of tumor
protein p53 (TP53), notably CDKN1A, followed by gradual down-regulation of cell-
cycle associated genes. Also within the first 2 h, PMA induced immediate early
genes including transcription factor genes encoding proteins implicated in macrophage
differentiation (EGR2, JUN, MAFB) and down-regulated genes for transcription factors
involved in immature myeloid cell proliferation (MYB, IRF8, GFI1). The dense time
course revealed that the response to PMA was not linear and progressive. Rather,
network-based clustering of the time course data highlighted a sequential cascade of
transient up- and down-regulated expression of genes encoding feedback regulators,
as well as transcription factors associated with macrophage differentiation and their
inferred target genes. CAGE also identified known and candidate novel enhancers
expressed in THP-1 cells and many novel inducible genes that currently lack functional
annotation and/or had no previously known function in macrophages. The time
course is available on the ZENBU platform allowing comparison to FANTOM4 and
FANTOM5 data.
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INTRODUCTION
11q23 chromosomal translocations fusing the mixed lineage
leukemia (MLL) gene (official gene symbol: KMT2A) with
any one of >60 partners lead to aggressive leukemias with
poor prognosis (Liang et al., 2017; Prange et al., 2017). One
of the two most common fusion partners AF9 (official gene
symbol: MLLT3) is involved in the primary translocation in
the widely studied acute myeloid leukemia (AML) cell line,
THP-1. THP-1 cells were originally established from peripheral
blood cells of a 1 year old boy with an AML-M5 leukemia
carrying a t(9;11)(p22;q23) translocation (Tsuchiya et al., 1980).
A subsequent study demonstrated that upon treatment with
phorbol esters, THP-1 cells become adherent and acquire many
functional characteristics of mature macrophages (Tsuchiya et al.,
1982). Partial differentiation could also be elicited in these cells
with the therapeutic agonist all-trans-retinoic acid (ATRA) (Chen
and Ross, 2004). Antisense down-regulation of the MLL-AF9
fusion transcript in THP-1 cells leads to growth inhibition but
does not drive differentiation (Pession et al., 2003; Suzuki et al.,
2009). On the other hand, differentiation with either phorbol
myristate acetate (PMA) or ATRA was associated with down-
regulation of MLL-AF9 and growth inhibition (Pession et al.,
2003; Chen and Ross, 2004).
The KMT2A/MLL gene encodes an epigenetic modifier,
histone lysine methyl-transferase 2A (Hess, 2004). The oncogenic
activity of the MLL-AF9 fusion product is mediated in part
through another epigenetic modifier, DOT1L, a histone 3
lysine 9 (H3K9) methyltransferase that in turn regulates target
genes in the HOX gene clusters and MEIS1 (Nguyen et al.,
2011). Genome-wide analysis of MLL-AF9 binding in THP-
1 cells revealed a substantial overlap with enhancers bound
by RUNX1, a transcription factor that regulates myeloid
differentiation and is itself commonly involved in leukemogenic
translocations (Prange et al., 2017). These studies identified
a novel target of MLL-AF9, the transcription factor ZNF521.
In mice, ZNF521 was enriched in hematopoietic stem cells
(HSC) and germ line mutation impacted stem cell self-renewal.
Knockdown of ZNF521 in THP-1 cells led to cell cycle arrest
and partial differentiation (Garrison et al., 2017; Germano et al.,
2017). Other genes that apparently contribute to dysregulated
proliferation downstream of MLL-AF9 in either THP-1 cells
or in mouse models include those encoding the transcription
factor SALL4 (Yang et al., 2017) and the protooncogene EVI1
(Bindels et al., 2012).
Differentiation therapy involves forcing cells to cease
proliferation and undergo terminal differentiation (Sachs,
1982). Such therapy with ATRA is one of the success stories
in leukemia treatment but is applicable to only around 10% of
AML cases (Ma et al., 2017). THP-1 cells provide a model system
to investigate other potential differentiation therapy agents in
aggressive AML. The process of differentiation of THP-1 cells
has been studied in detail at the transcriptomic level as a model
both of inhibition of leukemic proliferation and of macrophage
differentiation. Differentiated THP-1 cells are commonly used
as a tractable model for human monocytes (Bosshart and
Heinzelmann, 2016), recently exploited in functional genomics
using CRISPR-Cas9 deletion (Goetze et al., 2017; Osei Kuffour
et al., 2018; Palazon-Riquelme et al., 2018).
The original THP-1 line became adherent in response to PMA
within 3 h, but with progressive adaptation to tissue culture the
cells became more resistant to differentiation with adherence
delayed until 48 h of stimulation (Tsuchiya et al., 1982). The
line is epigenetically unstable; the relative proportion of cells
expressing markers such as CD4 (associated with undifferentiated
cells) and undergoing differentiation in response to PMA changes
with time in culture (Cassol et al., 2006). Subclones can be
selected from the parent line currently available from ATCC that
restore the original phenotype and either do, or do not, respond
to PMA. In order to study the process of differentiation in a
population in which the majority of cells respond synchronously,
the FANTOM4 consortium cloned THP-1 cells obtained from
ATCC by limiting dilution and chose one subclone in which
>90% of cells became adherent within 48 h of addition of PMA
(Suzuki et al., 2009).
Alongside microarrays, the consortium used CAP Analysis
of Gene Expression (CAGE) to identify regulated promoters
across a time course of differentiation. These studies identified
a cohort of transcription factor genes rapidly down-regulated
following PMA addition. SiRNA knockdown of a subset of these
genes (CEBPG, CEBPA, FLI1, GFI1, HOXA9, MYB and the
oncogenic MLL-AF9 fusion transcript) produced changes in gene
expression that partly mimicked the effects of PMA (Suzuki et al.,
2009). A subsequent study revealed combinatorial impacts of
several inducible miRNAs that also contribute to cell cycle arrest
(Forrest et al., 2010).
The central conclusion of the FANTOM4 analysis (Suzuki
et al., 2009) was that numerous regulated genes contribute
to a complex network in which reduced expression of anti-
differentiation/pro-proliferation genes is as essential as increased
expression of regulators that promote differentiation. The
FANTOM5 consortium extended the use of CAGE to generate
a promoter-based transcriptional atlas for humans and mice
(Forrest et al., 2014) and recognized that with sufficient depth
of sequencing, CAGE could also detect RNAs derived from
active enhancers, termed eRNAs (Andersson et al., 2014).
CAGE profiling enabled analysis of enhancer profiles of human
monocyte subsets (Schmidl et al., 2014) and a dense time course
of the response of human monocyte-derived macrophages to
lipopolysaccharide (Baillie et al., 2017). In the macrophage time
course, and in several other systems studied (Arner et al., 2015) a
transient pulse of eRNA from transcribed enhancers was detected
prior to the detection of promoter activity of inducible genes.
One limitation of the earlier FANTOM4 study of THP-
1 differentiation (Suzuki et al., 2009) was that the depth of
sequencing of CAGE libraries was not as high as in subsequent
studies so that transcription from enhancer loci could not be
detected. In addition, the time course was insufficient to support
resolution of the temporal of waves of transcriptional regulation.
The FANTOM5 studies (Forrest et al., 2014) prompted us to
reanalyze the time course of differentiation of THP-1 cells using
CAGE with a view to further dissection of regulated promoters,
enhancers and the complex transcriptional network that drives
differentiation in this model.
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The cellular commitment to differentiation or division usually
occurs in the G1 phase of the cell cycle and differentiation
of THP-1 cells is associated with cell cycle inhibition, with
accumulation of cells in G1 and in G2/M (Chen and Ross, 2004;
Gray et al., 2005; Gutsch et al., 2011). The FANTOM4 analysis
revealed down-regulation of cell cycle related genes in response
to PMA, with promoters enriched for E2F motifs (Suzuki et al.,
2009). A set of 700 genes transcriptionally regulated in the
human mitotic cell cycle has recently been generated based upon
transcriptional network analysis of multiple datasets, including
FANTOM5, and detailed curation and validation (Giotti et al.,
2018). Some of these genes have more than one promoter
and have other functions unrelated to the cell cycle in specific
cell types. The set includes many genes associated with DNA
repair and feedback regulation. Since the hallmark of leukemia
is dysregulated proliferation we have examined in detail the
coordinated expression of these cell cycle genes in THP-1 cells
during PMA-induced growth inhibition. The objective was to
further validate some of the novel cell cycle-related genes and
to identify potential loss or gain of genes or gene expression
within this co-expression cluster that might contribute to
leukemogenesis and could assist with the development of
differentiation therapies.
MATERIALS AND METHODS
Cell Culture and RNA Extractions
THP-1 cells (high differentiation clone 5, from the FANTOM4
consortium, passage number 8 (P8), provided by Dr. Mark
Barnett, The Roslin Institute, United Kingdom) were
cultured in sterile-filtered (0.2 µm) RPMI1640 medium
with HEPES modification (25 mM HEPES + NaHCO3)
(R5886 Sigma-Aldrich, Gillingham, United Kingdom), 10%
heat inactivated fetal bovine serum (FBS, GE Healthcare,
PAA laboratories, Pasching, Austria), 1x Glutamax (35050-
038, Gibco), 1 mM sodium pyruvate (11360-039, Gibco), 1x
MEM non-essential amino acids solution (11140-035, Gibco),
50 µM 2-mercaptoethanol (31350-038, Gibco) and penicillin-
streptomycin (16 U/ml and 16 µg/ml, Gibco) (THP-1 medium).
Cells were incubated at 37◦C, 5% CO2 and their concentration
was maintained between 2 × 105 – 8 × 105 cells per ml by
splitting in half three times a week. For the THP-1 differentiation
time course, THP-1 cells were grown up at a low passage number
(typically 2 or 3 passages from the P8 stock). The day before the
start of the differentiation, cells were counted by hemocytometer
and for each time point between 3 × 106 and 5 × 106 cells were
pelleted and resuspended in 10 ml fresh medium. THP-1 cells
were then differentiated by adding 30 ng/ml (48.6 nM) phorbol
12-myristate 13-acetate (PMA; P1585, Sigma-Aldrich) in DMSO.
The cells were plated on a Sterilin bacteriological plate and at
appropriate time points, the cells were lifted off by flushing with a
blunt-end needle syringe, resuspended in 1 ml of RNA Bee (AMS
Biosciences, Frienswood, TX, United States) and frozen at−80◦C
for later extraction. Medium was not changed for the duration of
the experiment to avoid initiation of a serum-specific response
during the time course. For each experiment, one culture was
used to set up two batches of cells. The first batch was treated
with PMA on the morning of the first day. Time points between 0
and 12 h were taken from this batch. The second batch from the
same culture was treated with PMA in the evening of the first day
(which is the 0 h time point from this batch, taken at the same
time as the 12 h time point of the first batch). All cells were then
incubated overnight. On the morning of the second day, the 24 h
time point of the first batch and the 12 h time point of the second
batch were taken, followed by time points between 12 and 24 h
taken from the second batch. Batches had several overlapping
time points (0, 12, 24, and 36 h) to ensure that cells were at
similar state of differentiation. RNA was extracted from the RNA
Bee lysate according to manufacturer’s instructions. Extracted
RNA was treated with DNase I (Ambion DNase kit AM1906,
Thermo Fischer Scientific) and the quantity and quality assessed
using a NanoDrop spectrophotometer ND-1000 (Nanodrop
technologies, Wilmington, DE, United States) and Agilent RNA
ScreenTape System (Agilent Technologies, Santa Clara, CA,
United States) according to manufacturers’ instructions. Only
RNA samples with RINe values (Imbeaud et al., 2005) around or
above 8 (out of 10) were used for CAGE sequencing.
Cap Analysis of Gene Expression (CAGE)
Time points chosen for CAGE sequencing were hourly from
0 to 12 h, two hourly from 12 to 18 h, and then at 24,
36, 48, and 96 h. At least three replicates of each time point
were included. Eight samples of 5 µg RNA each were made
into one CAGE library following the protocol adapted from
Takahashi et al. (2012). All the primer sequences were taken
from Takahashi et al. (2012) and primers were synthesized by
IDT (Coralville, IA, United States). A detailed description of the
CAGE protocol and associated bioinformatic analysis is provided
in Supplementary File S1. Results for 66 samples were processed
using the R/Bioconductor package CAGEr (Haberle et al., 2015).
All 66 samples were normalized to a power law distribution
(Supplementary File S1), with expression levels presented as
tags per million (TPM). The full quality assurance process
for CAGE sequencing is outlined in Supplementary File S1.
TSS were mapped to the human genome, version GRCh38.p9.
The normalized and aggregated groups of TSS (clusters of
transcription start sites; CTSS) were then annotated with gene
names as described in Supplementary File S1.
Network Analysis of Gene Expression
Patterns of gene expression during differentiation were visualized
using the network analysis tool Graphia Professional version
2.01. Mean expression values across replicates for CTSS with at
least 10 TPM in at least one sample were uploaded into the
Graphia Professional software. Sample-to-sample analysis was
performed using a correlation coefficient threshold of r ≥ 0.95,
as indicated in the Results. Two samples, both at the 4 h time
point, were found to be outliers, probably due to low level of
mapped reads (2.7 and 6.2 × 106 reads). These were removed
from subsequent analysis. Gene-to-gene analysis was performed
using a correlation coefficient of r ≥ 0.75. Clusters of genes with
1Now BioLayout, available at http://biolayout.org
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similar expression patterns were determined with the Markov
Clustering Algorithm (MCL) at an inflation value (determining
granularity of the clusters) of 1.7. A list of genes associated
with cell proliferation was obtained from Giotti et al. (2018)
and a list of human transcription factors from Lambert et al.
(2018). Further network analysis was performed on these subsets
of genes, with correlation coefficients and inflation values as
described in section “Results”. DAVID (Database for Annotation,
Visualization and Integrated Discovery2) was used to identify
functionally enriched biological themes based on gene ontology
(GO) annotations, using the Functional Annotation Clustering
tool (Huang et al., 2007). High annotation scores indicate
significant enrichment for groups of related GO terms.
Analysis of Transcription Factor Binding
Motifs
Activities of transcription factor binding motifs were estimated
using MARA (Suzuki et al., 2009) using all CTSS with at least
10 TPM in at least one sample, excluding the mitochondrial
chromosome and considering conserved motifs in the region
−300 to +100 bp of the midpoint of the CTSS. Motif names
are based on the set of consolidated position weight matrices
for human transcription factors curated for the earlier project
(Suzuki et al., 2009), available at http://swissregulon.unibas.ch/sr/
fantom4.
Analysis of Putative Enhancer
Expression
Candidate enhancers were identified as bidirectional TSS as
described (Andersson et al., 2014) at two levels of stringency. The
more stringent set (∼1000 loci) required at least two libraries with
more than one CAGE tag for each CTSS, and for the enhancers
an absolute directionality score of less than 0.8, and bidirectional
tags in more than two samples. For the less stringent set (∼2500
loci), the criteria were >1 tag per CTSS in at least one sample,
and bidirectional tags for each enhancer in at least one sample.
All bidirectional TSS regions closer than 500 bp to an annotated
TSS and closer than 100 bp to an exon were removed to avoid
detection of promoters of protein-coding genes. The analysis
was done with use of the CAGE analysis package CAGEfightR
(Thodberg et al., 2019), and the ported enhancer detection scripts
from Andersson et al. (2014)3.
Validation of Gene Expression Levels
With Quantitative Reverse Transcriptase
PCR
Gene expression levels detected by CAGE were validated for
representative genes using quantitative reverse transcriptase
polymerase chain reaction (qRT-PCR) on the same RNA
samples. cDNA was synthesized using Superscript III Reverse
Transcriptase (Invitrogen) according to manufacturer’s
instructions, using 500 ng of total RNA and 100 ng of random
primers. The ribonuclease inhibitor used was RNasin Plus
2http://david.ncifcrf.gov
3https://github.com/anderssonlab/CAGEfightR_extensions
(Promega, Madison, WI, United States; 20 units per reaction)
and extension at 50◦C was for 60 min. The resulting cDNA
was diluted 1:1 with water. Standard curves were established
using four concentrations of starting RNA: 12.5, 6.25, 3.13, and
1.56 ng/µl. qRT-PCR was carried out using SYBRGreen (Roche,
Mannheim, Germany) in a Roche Light Cycler 480 according
to manufacturer’s instructions. Samples were pre-incubated at
95◦C for 5 min (ramp rate 4.40◦C/s), then amplification steps
were repeated for 45 cycles. Amplification steps were 95◦C for
10s (ramp rate 4.40◦C/s), 60◦C for 15 s (ramp rate 2.20◦C/s) and
70◦C for 30 s (ramp rate 4.40◦C/s). Afterward, the melting curve
for primers was measured by incubating at 95◦C for 5s (ramp
rate 4.40◦C/s), 65◦C for 1 min (ramp rate 2.20◦C/s) and then the
temperature was increased to 97◦C by 0.11 C◦/s. At the end, the
plate was cooled for 30 s at 40◦C. Calculations were performed
using the Roche Light Cycler 480 software, with the Advanced
Quantification setting. 1Ct was calculated with previously
established values of primer efficiencies from the standard curves
(calculated using the same software, by using Abs Quant/2nd
Derivative Max setting). Primer sequences and efficiencies are
available in Supplementary File S1.
Analysis of the Cell Cycle in
Differentiating THP-1 Cells
Propidium iodide staining was used to examine the cell cycle.
1 × 106 cells were pelleted at 400 g for 5 min and resuspended
in 1 ml of ice-cold 70% ethanol and then left at 4◦C for at least
24 h (up to 2 months). On the day of the flow cytometry, cells
were spun down at 16,000 g for 5 min and then washed twice with
PBS. 300 µl of the Cell Cycle Staining Solution [38 mM sodium
citrate, 10 µg/ml pancreatic RNase A (Signa-Aldrich), 68 µM
propidium iodide (Sigma Aldrich)] was added to the pellet.
Samples were incubated in the dark for 1–2 h and 300 µl of PBS
was added right before flow cytometry. Samples were analyzed
on a Fortessa cytometer (BD Biosciences, Franklin Lakes, NJ,
United States) using a 610 nm laser. Results were analyzed using
FlowJo software version 10.0.8r1 (Flow Jo LLC, Ashland, OR,
United States) by gating single viable cells by excluding doublets.
The final window showed the histogram of the area of propidium
iodide channel, which was examined using the cell cycle option
of FlowJo software by choosing the Watson (pragmatic) type of
analysis (Watson et al., 1987).
RESULTS
Characterization of the THP-1 Time
Course of Differentiation
PMA treatment of THP-1 high differentiation clone 5 cells was
carried out multiple times to harvest RNA for CAGE sequencing.
To ensure that differentiation from monocyte to macrophage
phenotype had occurred, changes in morphology and attachment
to the culture vessel surface were examined for each replicate.
Undifferentiated THP-1 monocyte-like cells grew in suspension,
with most cells not attached to the bottom surface of the vessel.
The THP-1 cells started to adhere around 6–8 h after addition of
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FIGURE 1 | Analysis of the cell cycle in THP-1 cells. (A) Prior to PMA stimulation; (B) 10 h post PMA stimulation; (C) 24 h post PMA stimulation; (D) 30 h post PMA
stimulation; (E) 48 h post PMA stimulation. Data were analyzed using FlowJo with the Watson (pragmatic) model. Line graph shows the number of cells in each
phase, taken from FlowJo software; X axis shows the propidium iodide fluorescence and Y axis shows cell count. Arrow in (B) highlights the immediate rapid decline
in S phase entry in response to PMA. Pie chart shows the proportion of cells in each phase. Purple – G1 phase; orange – S phase; green – G2 phase.
30 ng/ml of PMA. They then began to develop more macrophage-
like morphology, with the most dramatic difference observed at
48–96 h. Their shape changed from being round to more variable
and the cytoplasm contained more phagocytic vacuoles. At each
time point there were a few cells where the morphology indicated
they were more macrophage-like than the majority of cells. More
than 99% of the cells were adherent and had similar morphology
by the end of the time course at 96 h, indicating that this culture
of THP-1 clone 5 had retained its high differentiation phenotype.
Prior to addition of PMA, the majority of the THP-1 cells
were in G1 (growth) phase with approximately one third in
S (DNA synthesis) phase (Figure 1A). After 10 h, the profile
of DNA content detected by FACS was clearly changed. The
number of cells in S phase was dramatically reduced and by
24 h there were <10% of cells with intermediate DNA content
between 2N (G1 phase) and 4N (G2 phase) (Figures 1B,C).
This low proportion was maintained for the rest of the time
course (Figures 1D,E). The proportion of cells with 4N DNA
content (G2) actually increased by 24 h as cells that had already
entered S phase completed DNA synthesis. The proportion of
cells in G2 phase gradually declined thereafter. These results
indicate that differentiation of THP-1 cells to a macrophage
morphology was preceded by a rapid decline in proliferation due
to blocks at both entry to S phase and the well-documented G2-
M phase (cytokinesis/cell division) check point, most commonly
associated with DNA damage (Stark and Taylor, 2004).
To ensure that the differentiation of THP-1 cells from pro-
monocytic to macrophage-like phenotype was supported by
changes in gene transcription, gene expression levels derived
from qPCR were assessed for two relevant markers, MYB
which encodes a transcription factor associated with proliferating
hematopoietic cells (reviewed by Zhou and Ness, 2011) and
monocyte differentiation antigen gene CD14 (Bazil et al., 1982;
Wright et al., 1990). MYB was down-regulated during THP-1
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differentiation in the earlier FANTOM4 study (Suzuki et al.,
2009). In the present study, MYB expression was also found
to decrease after PMA stimulation in all biological replicates,
with the lowest level at around 2:30–3 h (Supplementary
Figure S1). CD14, which was not detected in undifferentiated
THP-1 clone 5 cells, consistent with FACS analysis of the parent
THP-1 line (Bosshart and Heinzelmann, 2016), was not up-
regulated until the last few points of the time course, from 24 h
(Supplementary Figure S1).
Changes in Gene Expression During
Differentiation of THP-1 Cells
The time course of THP-1 differentiation for all of the replicates is
available on the ZENBU genome browser4. The browser enables
gene-specific search and includes the FANTOM5 promoter and
enhancer tracks and the UCSC CpG island track. To compare
the detailed time course with the earlier study (Suzuki et al.,
2009) that had fewer time points, CAGE sequencing results
were first analyzed for index genes highlighted as markers in
that study. Figure 2A shows the time courses of representative
macrophage differentiation marker genes. As with the qPCR
results, CD14 increased late in the time course. Consistent with
the previous data, CD14 was most strongly induced between 48
and 96 h. ICAM1 was induced maximally by around 24 h, ITGAM
(encoding CD11B) increased after 12 h and APOE increased from
around 18 h. By contrast to the earlier study, but in keeping
with other results (Datta et al., 1992), the transcript encoding
the growth factor receptor CSF1R was highly expressed by THP-
1 cells without differentiation (200 TPM) but slowly induced
a further 7-fold by PMA, reaching a maximum around 96 h.
CSF1R is set as the default view on the ZENBU browser. The time
course of CSF1R induction resembled the induction of CD36,
proposed as a marker of differentiation in this system (Maess
et al., 2010). CD36 mRNA was induced by 1 h and continued
to increase throughout the time course. THP-1 cells respond to
CSF1R ligand, CSF1 (Datta et al., 1992) and were previously
shown to express CSF1 mRNA (Rambaldi et al., 1988). In the
present study, CSF1 mRNA was induced with a very similar
time course to CSF1R suggesting the likely involvement of an
autocrine stimulatory loop in differentiation. CSF1 mRNA is also
induced during the differentiation of primary human monocytes
(Horiguchi et al., 1986) and indeed the highest level of expression
in the FANTOM5 dataset is in monocyte-derived macrophages.
The transcriptional regulation of SPP1 (encoding
osteopontin), representative of a cluster of genes induced
between 12 and 24 h and associated with adherence, was
dissected in detail previously (Suzuki et al., 2009). SPP1 was
also massively induced by PMA in each time course replicate
generated for this study. The timing of induction varied between
replicates, so that the expression was highly variable between 6
and 24 h. Figure 2A shows mean data, averaged across replicates.
The variation suggested that osteopontin is induced during the
process of adhesion and that cluster analysis of the replicates
independently might identify other genes that are involved
in this key event.
4http://fantom.gsc.riken.jp/zenbu/gLyphs/#config=Gazova_THP1_differentiation
A key feature of the PMA time course also dissected previously
was the rapid down-regulation of genes for transcription factors
involved in cell cycle regulation, notably MYB and E2F1,
associated with growth arrest and induction of differentiation.
Knockdown of some of these factors was sufficient to induce
growth arrest and partial differentiation (Suzuki et al., 2009).
Figure 2B shows a subset of these transcription factors. CAGE
sequencing showed that MYB was expressed from two promoters,
both of which were down-regulated rapidly in response to
PMA. The related transcription factor gene, MYBL2 was highly
expressed at the start of the time course (16 fold higher than
the combined expression of the two MYB promoters) and
declined later than MYB. MYBL2 was not assessed in the
previous analysis. E2F1 was maximally repressed by around
12 h. GFI1 has been identified as a transcriptional repressor
of target genes of the macrophage transcription factor, PU.1
(encoded by SPI1) (Wilson et al., 2010; Barth et al., 2019). In
THP-1 cells, GFI1 was expressed from 4 separate promoters
and rapidly down-regulated by PMA (Figure 2B). Consistent
with repression of entry into the cell division cycle, the G1/S
cyclin gene CCNE2 was rapidly repressed to undetectable
levels (Figure 2C). Cell cycle-associated transcripts for genes
associated with S phase and mitosis (Giotti et al., 2018) such as
PCNA, BUB1, AURKA, CDK4 and the M phase cyclin, CCNB1,
declined more slowly and progressively (Figure 2C), presumably
as individual cells competed the cycle (Figure 1). Many of
these transcripts showed some evidence of re-expression at 48–
96 h (for example E2F1, CCNE2 and PCNA in Figure 2),
which may reflect expansion of the small subset of cells
that is resistant to PMA-induced differentiation even in this
cloned line.
The time course of the loss of positive cell cycle regulators
in response to PMA suggests that this may be a consequence
rather than a cause of the block to S phase entry (Figure 1). The
FANTOM 4 project did not analyze the expression of inducible
cell cycle repressors. Others reported that the cell cycle inhibitor
CDKN1A (p21WAF) was induced by PMA at the mRNA and
protein level in THP-1 cells (Akashi et al., 1999; Traore et al.,
2005). The induction of CDKN1A was associated with the loss
of phosphorylated CDK2 protein, which was linked in turn to
selective inhibition of phosphorylation of RB (retinoblastoma
protein). Figure 2C shows that CDKN1A was induced from
almost undetectable levels within 1 h and thereafter sustained at
high levels throughout the time course.
These initial studies indicate that the current dataset broadly
reproduces the temporal cascade of cell cycle arrest and
monocyte-macrophage differentiation seen previously (Suzuki
et al., 2009) and show that the increased temporal resolution of
the present study was informative. We therefore undertook a
refined network analysis of the data.
Patterns of Gene Expression Throughout
Differentiation
CAGE sequencing data values (means for each replicate;
N = 2–6) were loaded into the network analysis tool Graphia
Professional to find patterns of gene activation and repression
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FIGURE 2 | Gene expression during differentiation of THP-1 cells. X axis shows time points from 0 to 96 h after administration of PMA; Y axis shows average
expression by CAGE analysis in tags per million (TPM). (A) Macrophage differentiation marker genes CD14, ICAM1, ITGAM, APOE, CSF1R, CD36, SPP1, CSF1.
(B) Transcription factor genes MYB (two CTSS), MYBL2, E2F1, GFI1 (four CTSS), SPI1. Multiple CTSS associated with the same gene are shown by lighter colored
sections of the bars. (C) Inducible cell cycle repressor genes CCNE2, PCNA, BUB1, AURKA, CDK4, CCNB1, CDKN1A. (D) Color code for time points on the X axis.
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across the time course. To look for general trends across all
replicates, a sample-to-sample network at 18 different time points
was generated using a correlation coefficient of ≥0.95. The
sample-to-sample network (Figure 3A) highlights the global
transcriptomic transition as the time after treatment increased.
The transcriptome of samples at 0 h (deep red) were most
different from those at 96 h (deep purple). Samples from other
time points lie between these two, moving from red (1 h) through
orange and yellow (2–6 h), green (7–12 h), and blue (14–
48 h).
Next, CTSSs were correlated with each other based on the
mean expression at 18 time points (to create a gene-to-gene
network). The analysis was done with a correlation coefficient
threshold of 0.85, which included 10,168 nodes out of 11,360
possible CTSS (see section “Materials and Methods”). Expression
patterns of excluded CTSSs were not correlated with any other
CTSS at a correlation coefficient of 0.85. A network graph
comprising one large element of 10,046 nodes and 53 smaller
unconnected elements of between 2 and 11 nodes was generated
using Graphia Professional. Markov clustering with an inflation
value of 1.7 partitioned the graph into clusters of CTSS with
related expression profiles. Figure 3B shows the result for
the main element. There were 92 clusters with 10 or more
nodes. A number of clusters showed distinct patterns of gene
expression during differentiation. The largest of these are shown
in Figure 3C. The clusters in which the key genes discussed above
were found are shown in Table 1. A full list of all the clusters and
the mean expression patterns of those with 10 or more nodes is
presented in Supplementary Table S1.
The largest cluster, Cluster001, contained genes which code
for proteins associated with mature macrophage functions,
including surface markers (CD14, CD163, ITGAM), lysosome
activity, transmembrane location and integrin complex. The
most significantly enriched GO term was lysosome (enrichment
score 14.8). This cluster contained genes with expression that
steadily increased throughout differentiation, peaking at the
end of the time course. Cluster002 declined progressively
across the time course and showed high enrichment scores for
terms associated with cell cycle (enrichment score 31.7) and
mitochondria (enrichment score 21.1). Three hundred and sixty
seven (17%) of the genes in this cluster were contained in an
annotated list of 701 cell cycle genes (Giotti et al., 2018). These
two clusters are consistent with the major phenotypic impacts of
PMA, growth arrest and macrophage differentiation.
Aside from these two clusters, the network analysis revealed
that many transcripts were induced or repressed transiently.
By 1 h after PMA treatment, early response genes with
functions such as transcriptional activation were highly expressed
(Cluster020 peaking at 2 h then declining rapidly and Cluster007
peaking at 4 h). Both these clusters were associated with GO
terms relating to regulation of transcription (enrichment scores
2.7 and 3.9, respectively). Expression of the genes in Cluster003
began to rise after 1 h and peaked between 5 and 8 h. They were
associated with both the cell cycle (enrichment score 4.9) and
cell-cell adhesion (enrichment score 4.1). Expression of genes in
Cluster004 slowly increased from the 2 h time point, peaking
between 10 and 18 h, and this cluster was enriched for GO terms
relating to lysosome (enrichment score 5.3). Images of the average
expression profiles are shown in Figure 3C.
Cell Cycle Gene Expression Throughout
Differentiation
Cancer is characterized by abnormalities in cell proliferation,
particularly the escape of the cancer cells from the normal
controls on cell division (Sachs, 1982). In the analysis of the
whole dataset, the second largest cluster (Cluster002) contained
many genes associated with cell proliferation and the averaged
expression profile of this cluster showed a decline during the
time course with a small increase at 96 h. Note that by
contrast to earlier studies (Nguyen et al., 2011; Garrison et al.,
2017; Germano et al., 2017; Prange et al., 2017) (see section
“Introduction”) the set of down-regulated transcripts did not
include KMT2A (MLL), DOT1L, RUNX1 or ZNF521, implicated
in primary leukemogenic transformation in AML. Each was
expressed constitutively by THP-1 cells and unchanged upon
differentiation. The cell cycle-associated cluster was explored in
more detail by further clustering the expression profiles of the
2,158 genes separately, at higher stringency. A sample-to-sample
analysis (r ≥ 0.9) showed that for this group of genes, the later
time points were quite distinct, but the earlier time points (from
0 to 14 h) were relatively similar with a weak correlation between
time point and position in the network (Figure 4A). The gene-
to-gene analysis was run at a correlation coefficient threshold
of 0.95, which included 1540 nodes connected by 17,446 edges.
The network was then clustered with an MCL inflation value
of 1.7. 618 nodes of the original Cluster002 were excluded at
this threshold. We hypothesized that genes involved in different
phases of the cell division cycle, or with different mRNA stability,
might decay with distinct temporal profiles Consistent with
that view, the annotated cell cycle genes appeared in specific
subclusters with distinct profiles of decay with time (Figure 4B).
For example, Subcluster002 with 99 nodes had none of the
reported cell cycle genes (Giotti et al., 2018), a highly significant
departure from expected (P = 7 × 10−6). Overall expression in
this cluster dropped very early in the time course. This cluster
contains monocyte-associated transcription factors (IRF8, GFI1).
These factors, as well as MYB and MYBL2 (which are also in
the larger Cluster002 but did not form a part of a subcluster)
have myeloid-specific roles in proliferation and down-regulation
using siRNA can drive growth inhibition (Suzuki et al., 2009).
Subcluster003 and Subcluster004 had a significant excess of cell
cycle genes (P < 1 × 10−5 and P = 3 × 10−5 respectively). For
these clusters, average expression declined slowly after 10 h and
both had a small rise at 96 h, not seen in Subcluster002. Both these
clusters had equal numbers of genes associated with S and G2/M
phase of the cell cycle. In contrast Subcluster010 with 17 nodes
had 10 G2M genes and no S phase genes (P = 5× 10−6). Average
expression was relatively flat until 18 h when it dropped rapidly.
Using the Bonferroni method to correct for multiple testing, a
P-value of 0.002 would be equivalent to the accepted threshold
for significance of 0.05, so these differences are highly significant.
The full list of subclusters and averaged expression profiles are
provided in Supplementary Table S2.
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FIGURE 3 | Network analysis of patterns of gene expression throughout differentiation of THP-1 cells. (A) Sample-to-sample analysis. Each node (sphere)
represents the average of replicates at a time point, colored as shown in Figure 2D, indicating hours after addition of PMA. Edges between nodes show correlations
of ≥0.95. (B) Gene-to-gene analysis showing the main element of the full network. Nodes represent genes (TSS) and the edges between them represent
correlations of ≥0.85. MCL clustering was performed at an inflation value of 1.7 and nodes are colored according to their membership in a cluster. (C) Clusters of
nodes that are differentially expressed across the time course. Orientation is the same as (B) but edges and other clusters have been removed for ease of
visualization. Color of nodes shows the cluster to which nodes were allocated; histograms (colored the same as the nodes in the cluster) show the average
expression patterns of the genes within the clusters. Color code for the X axis is as for Figure 2.
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TABLE 1 | Clusters associated with key genes from network analysis.
CTSS ID Cluster number
CD14 001
ICAM1 001
ITGAM 001
APOE 001
CSF1R 001
CD36 001
SPP1 001
MYB p2 002
MYBL2 002
E2F1 002
GFI1 p1 002
GFI1 p2 002
GFI1 p3 002
GFI1 p4 002
CCNE2 002
PCNA 002
BUB1 002
CDK4 006
CDKN1A 012
SPI1 014
AURKA 273
CCNB1 273
MYB p1 332
The analysis was based on averaged values over the whole dataset. Where present,
p1 – pn indicate the detection of additional CTSS attributed to the same gene by
the CAGE analysis.
A previous study (Giotti et al., 2018) identified 701 genes that
were expressed/induced in multiple cell types specifically in S
phase and G2/M phases of the cell cycle. Of these, 561 (80%)
were expressed in THP-1 cells, represented by 617 promoters.
These 617 promoters were selected from the filtered dataset of
mean values and analyzed separately. When clustered at R≥ 0.75,
599 promoters were included in the analysis and 512 of these fell
into the largest cluster (named CC-cluster01) with an average
expression pattern which declined slowly until 10 h and then
more steeply to 48 h, after which there was a small increase in
average expression (Figure 4C). This group included the classic
proliferation markers mentioned earlier. This finding provides
further support for the annotation of these genes as cell cycle-
related. A second cluster of 21 nodes (CC-cluster02) showed a
small decline in expression from 0 h, with a large increase at 96 h.
Other smaller clusters containing 2 – 11 unique genes showed
similar expression patterns to the whole dataset (Figure 4C).
The full CC-cluster lists and averaged expression profiles are
provided in Supplementary Table S3. The set of 150 cell-cycle
genes for which promoter activity was not detected in THP-1
cells is provided in Supplementary Table S4. In most cases, the
apparent lack of expression is an issue of promoter annotation,
and there is, in fact, expression of promoter activity in the region
of the corresponding gene evident in the FANTOM5 dataset.
For example, our data, and the FANTOM5 data, reveal that the
transcript encoding the key regulator CDC25B, which is essential
for G2/M cell cycle progression in AML (Didier et al., 2008) is
expressed in THP-1 cells but is primarily driven by a cluster of
three promoters that are internal to the annotated TSS in RefSeqs
NM_001287516, NM_001287517, and NM_001287518. This can
be seen in the data available on the ZENBU browser.
In summary the analysis of known cell cycle genes is consistent
with the shut-down of entry into S phase prior to the 10 h
time point as indicated by the cell cycle analysis (Figure 1) and
subsequent slow decay of S phase-associated transcripts as cells
complete the DNA synthesis phase of the cell cycle and are
blocked in G2/M.
Transcription Factor Gene Expression
Throughout Differentiation
In cells undergoing transitions in state, transcription factor gene
expression precedes the expression of the target genes being
regulated (Arner et al., 2015). Of 1639 transcription factors
curated recently (Lambert et al., 2018), 647 (39%) were expressed
in the filtered THP-1 dataset. The expression profiles of these
genes were used for further analysis. In a sample-to-sample
analysis including all time points (R ≥ 0.61), the 0 h time
point was an outlier, linking only with the 3 h time point
(Figure 5A). A gene-to-gene analysis of the 647 transcription
factor genes (796 promoters) was performed at a relatively
stringent correlation coefficient of R ≥ 0.85, which included 540
nodes (transcription factor genes) and 3026 edges (connections
between them at R ≥ 0.85). Clustering was performed at an
inflation value of 1.7 and clusters were named as TF-cluster01
etc. The clusters are shown in Supplementary Table S5 which
also contains histograms of mean activity of each cluster. The
much denser time course analyzed herein, compared to the
FANTOM4 project (Suzuki et al., 2009) highlights a temporal
cascade in which the large majority of the transcription factor
promoters exhibit regulated expression. Broadly speaking, there
is a set of clusters where the transcripts are progressively down-
regulated with different dynamics, a reciprocal set progressively
up-regulated and a third set in which expression is regulated
transiently (Figure 5B).
The transiently regulated transcription factors include the
so-called immediate early genes (IEG) that have been analyzed
in detail in other differentiation/activation time courses by the
FANTOM 5 consortium (Vacca et al., 2018). That analysis
identified a set of 42 protein-coding genes with promoters that
consistently drive a rapid, but transient, wave of transcription in
response to stimulus. A subset of these IEG was expressed by
differentiating THP-1 cells. TF-Cluster15 contains transcription
factors EGR1, EGR3, EGR4, JUNB, KLF2, KLF10 and MEF2D
which were fully induced within 1 h and thereafter declined
slowly. Other IEG had distinct patterns. EGR2, which has specific
functions in myeloid differentiation including regulation of
CSF1R transcription (Laslo et al., 2006; Krysinska et al., 2007), is
part of TF-cluster10 (also including ELK3, FOXP2, JUNB, TBX3,
and ZEB2) that peaks later around 8–10 h, around the time of
the first appearance of adherent cells. ZEB2 was shown recently
to be required for the establishment and maintenance of tissue
macrophage identity (Scott et al., 2018). By contrast to other
systems in which it is an IEG, and consistent with its known
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FIGURE 4 | Network analysis of cell cycle genes. (A) Sample-to-sample analysis of Cluster002, containing genes associated with the cell cycle and proliferation.
Nodes show averaged values for each time point and edges show correlations of ≥0.90 between nodes. Hours after addition of PMA are indicated. (B) Expression
profiles of subclusters generated by gene-to-gene analysis of Cluster002. Averaged values for each time point. Correlation coefficient was ≥0.95 and MCL inflation
value was 1.7. (C) Gene-to-gene analysis of 561 curated cell cycle genes (617 TSS) (Giotti et al., 2018) expressed during THP-1 differentiation. Nodes show
averaged values for each gene and edges show correlations of ≥0.75 between them. MCL inflation value was 1.7. Histograms show the averaged expression profile
for each cluster. Color code for the X axis is as for Figure 2.
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FIGURE 5 | Expression of transcription factors during THP-1 differentiation. (A) Sample-to-sample analysis of 647 curated transcription factors (796 TSS) (Lambert
et al., 2018) expressed during THP-1 differentiation. Edges show correlations of ≥0.61. Hours after addition of PMA are indicated. (B) Expression profiles of clusters
generated by gene-to-gene analysis of curated transcription factors. Averaged values for each time point. Correlation coefficient was of ≥0.85 and MCL inflation
value was 1.7. (C) Network analysis of transcription factor motif activity. Histograms showing average activity (as detected by MARA) of transcription factor motifs,
clustered at a correlation coefficient of ≥0.60 and MCL inflation value of 1.7. Color code for the X axis is as for Figure 2.
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functions in macrophage differentiation (Shen et al., 2016), JUN
was not induced rapidly but instead formed part of a progressive
differentiation cluster (see below).
Mean expression of transcription factor genes in the largest
cluster (TF-Cluster01) was maximal in untreated THP-1 cells
and declined rapidly in response to PMA. This down-regulated
cluster contains multiple transcripts associated with immature
myeloid cells and maintenance of the proliferative state, including
MYB, GFI1 (both shown in Figure 2B), IRF8 and RXRA.
Average expression of transcripts within TF-Cluster03 declined
more slowly; they include the core regulators of cell cycle
gene expression, E2F1 (Figure 2B) and FOXM1 (Giotti et al.,
2018). Several TF clusters show progressive up-regulation with
distinct profiles. TF-Cluster04 (including JUN, MAF, NR1H3)
increased across the whole time course, TF-Cluster11 (including
ATF3, TCF7L2) was induced earlier, and TF-Cluster02 (including
IRF1, FOXP1) was induced late, associated with terminal
differentiation. One highly induced transcription factor with a
unique expression profile that did not form part of a cluster was
MAFB, discussed further below.
MARA Analysis
Promoters contain motifs that are recognized by DNA binding
proteins. Where promoters share such motifs it is likely that they
are regulated by the same proteins, and expression correlates with
the number of copies of the relevant motif in the promoter region.
The analysis tool MARA (Suzuki et al., 2009), which calculates
motif activity based on this correlation, was used to analyze
the response of THP-1 cells to PMA. The results are shown in
Supplementary Table S6 and histograms of activity of selected
motifs across the time course are shown in Supplementary
Figure S2. A preliminary clustering analysis (r ≥ 0.6, MCL
inflation 1.7) showed four patterns of activity: declining or
increasing throughout the time course, transiently up-regulated
and transiently down-regulated (Figure 5C). These patterns
confirm the conclusions of the earlier work (Suzuki et al., 2009).
The imputed transcriptional activity of MYB and E2F1.5 motifs,
and of TFDP1, which binds cooperatively with E2F (Rubin et al.,
2005), was down-regulated progressively over the time course.
The activity of related motifs recognized by AP1 family members
(FOS; FOS{B,L1}_JUN {B,D}; FOSL2; JUN) increased rapidly, as
did the activity of the NFE2L2 and TGIF1 motifs (both factors
induced by PMA).
There was some evidence of increased activity of the IRF1,2,7
motif, consistent with the induction of interferon target genes
in Cluster032. Kubosaki et al. (2010) reported that the same
genes were expressed constitutively in THP-1 cells and were
targets of IRF8. Consistent with this and other studies (Phanstiel
et al., 2017), IRF8 was highly expressed by THP-1 cells (the
most abundant transcription factor mRNA) and repressed by
PMA, but the putative target genes were low in undifferentiated
cells and strongly induced. PMA also initiated clear and
transient increased activity of the EGR1.3 motif. Also consistent
with FANTOM4 data there was a decrease in activity of the
NFY{A,B,C} and octamer (POU2F1.3) motifs, although NFYB
and NFYC mRNAs (both highly expressed in THP-1 cells) were
not regulated by PMA.
The greater resolution of the current dataset permitted the
detection of regulated activity of additional motifs, notably the
NR4A2 (also recognized by NR4A1) and TFEB motifs. Both
NR4A1 and NR4A2 were amongst immediate early genes induced
by PMA. The TFEB motif, recognized by members of the
microphthalmia transcription factor family, is enriched in the
promoters of lysosome-associated genes (Sardiello et al., 2009;
Hume et al., 2010). Two members of this family, TFEC and TFE3,
were constitutively expressed in THP-1 cells but two others,
TFEB and MITF, were progressively induced in response to
PMA in parallel with lysosomal hydrolases (e.g., ACP2, CTSB,
LIPA) and components of the vacuolar ATPase (e.g., ATP6V0A1).
Conversely, we did not reproduce evidence of inducible activity
of SPI1 (PU.1), RUNX1.3 or SNAI1.3 motifs although transcripts
encoding the related transcription factors TWIST1 and SNAI1
were induced by PMA.
Enhancer Activation During THP-1
Differentiation
The increased depth of sequencing available in this dataset also
enables for the first time the detection of enhancer RNA (eRNA),
which derives from the transcriptional activity of regulated
enhancers, and inferred relationships with inducible promoters.
The eRNAs are rapidly degraded by the exosome complex
(Andersson et al., 2014) and accordingly, they are generally
detected at <1 TPM. Detection is therefore subject to stochastic
noise with median mapped reads of around 10 million per library.
Nevertheless, integration of the entire dataset enabled detection
of regulated bidirectional transcription associated with enhancers
annotated in the FANTOM5 dataset and identified additional
candidate enhancers. The identified enhancers were compared
to those identified in FANTOM 5. 1353 of the less stringent set
and 656 of the more stringent set were found in the full set of
∼63,000 enhancers (Andersson et al., 2014), indicating that this
analysis has discovered some potential novel enhancers. Both
sets were compared to the set of ATAC-seq peaks identified in
analysis of chromatin architecture of differentiation (Phanstiel
et al., 2017). Overlap was detected for 88 and 79% enhancers
in the more and less stringent sets, respectively. One novel
example highlighted in the chromatin analysis is the complex
BCL6/TPRG1 locus. BCL6 is implicated in cell cycle regulation
and interacts with TP53 and CDKN1A (Phan et al., 2005),
whereas there is little known of the biology of TPRG1. The
promoters of these two transcripts are separated by >200 kb
(see ZENBU Browser). The TSS of TPRG1 is located upstream of
the annotated RefSeq transcript NM_198485 at Chr3:188947237,
downstream of a TATA box. The differentiation time course
data confirm the rapid (within 1 h) and synchronous continued
induction of both transcripts, and the detectable induction of
enhancers with the intervening LPP locus. Figure 6 shows the
profile of the activity of each of these promoters/enhancers across
the time course. A similar co-regulated pattern was evident at
the MITF locus. The induction of MITF with time in response
to PMA was correlated with induction of the adjacent FRMD4B
gene and evidence of bidirectional transcription initiation in the
intervening genomic region.
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FIGURE 6 | Promoter and enhancer activity of BCL6 and TPRG1. Y axis shows expression levels in TPM; negative value (gray bars) indicates expression from the
reverse strand. X axis shows the time points (hours after administration of PMA; color code as shown in Figure 2).
To further confirm the validity of the enhancers found, they
were compared to every individual FANTOM5 enhancer set. The
THP-1 FANTOM5 library was the top hit for both sets, and other
myeloid libraries were overrepresented in the top of the list. 219
out of 1172 FANTOM5 THP-1 enhancers were confirmed in
the more stringent time course set. The results are available in
Supplementary Tables S7A,B.
The macrophage-specific transcription factor, PU.1 (encoded
by SPI1) is required for differentiation and controls the
expression of many macrophage-enriched genes in THP-1 cells
(Suzuki et al., 2009). SPI1 was expressed constitutively by THP-
1 cells and was not highly regulated by PMA. As noted above,
MARA did not reveal regulated activity of the PU.1/SPI1 motif
across the time course. The expression of SPI1 in AML cells
depends upon an enhancer around 16 kb upstream of the
TSS that binds the transcription factor SATB1 (Steidl et al.,
2007). The CAGE data (see ZENBU Browser) reveal that there
is abundant unidirectional transcription initiation from this
enhancer in THP-1 cells, likely driving an annotated lncRNA, that
is marginally up-regulated by PMA. SATB1 mRNA, on the other
hand, was progressively down-regulated in response to PMA.
Amongst other genes of interest, the MYB gene contains two
upstream and two intronic enhancers. A candidate enhancer in
the first intron was progressively down-regulated in response
to PMA. This same region, conserved across species, has
previously been implicated in regulated expression of Myb
in mouse erythroleukemia cells (Suhasini et al., 1997). The
data reveal a second major locus of regulated bidirectional
transcription in intron 9 (Figure 7). Previous studies of regulated
expression of CDKN1A have emphasized the impact of PMA on
promoter activity and the binding of transcription factor SP1.
The FANTOM5 study identified four enhancers in the region
of CDKN1A. One of these, at Chr6:36667005-36667447 (around
−12 kb relative to the TSS and conserved in mouse) was strongly
and rapidly induced by PMA (Supplementary Figure S3). The
progressive induction of the CSF1R gene in response to PMA
was preceded by increased antisense transcription initiation in
the first intron (Supplementary Figure S3), which contains
two enhancers including the highly conserved FMS intronic
regulatory element (FIRE) (Rojo et al., 2017). Finally, the
FANTOM5 data identified candidate enhancers between the
ITGAM (encoding CD11B) and ITGAX (CD11C) loci, both
genes induced late in differentiation by PMA, and the CAGE
data detect bidirectional transcription in the intergenic region
(Supplementary Figure S3).
DISCUSSION
This study used CAGE to analyze the transcriptional regulatory
networks that are initiated in response to phorbol esters in a
high differentiation clone of the THP-1 myeloid leukemia line.
The analysis of the cell cycle arrest is consistent with earlier
reports. Using the parent line, Traore et al. (2005) found a
similar proportion of cells in S phase in undifferentiated cells
and reported a complete inhibition of DNA synthesis (assessed
by BrdU uptake) in response to PMA within 24 h. They therefore
implicated a block to G1/S entry which is also evident from the
rapid loss of intermediate (S phase) DNA content in our study
(Figure 1). The persistence of cells with 4N DNA content in both
their study and ours indicates at least some of the cells are then
blocked at the G2/M checkpoint, as also seen in AML cells treated
with genotoxic agents (Didier et al., 2008).
Compared to the earlier analysis by the FANTOM4
consortium (Suzuki et al., 2009) we have analyzed a much
denser time course, sequenced at greater depth using next
generation sequencing platforms, and taken advantage of the
depth of data to perform a network-based analysis of the
temporal cascade. Minor differences between our study and
FANTOM4 in detection of specific genes (e.g., TP53, CSF1R) are
likely due to differences in sequencing technology/depth/error
rates/mapping and refinement of the human genome assembly
in two updates since the previous study (which was mapped
to hg18, NCBI Build 36.1, released in 2006). Where there are
differences, our data are validated by multiple replicates at
multiple time points and the precise location of the TSS. The
FANTOM5 consortium generated similar data for a number of
differentiation/activation cascades in other cell types (Arner et al.,
2015). Those data enabled the identification of eRNA derived
from active enhancers and provided evidence that transient
activation of eRNA transcription preceded the activation of
target genes. The data generated for THP-1 cells complement
and extend the detailed chromatin analysis published by others
(Phanstiel et al., 2017), which compared only the unstimulated
and fully differentiated states (after 72 h) and used the parent
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FIGURE 7 | Expression of MYB intron 9 putative enhancer during THP-1 differentiation. (A) Screenshot of Zenbu browser showing MYB intron 9 putative enhancer
(circled in red). (B) Expression of two MYB promoters and the putative intron 9 enhancer. Y axis shows expression levels in TPM; negative value (gray bars in panel
on right) indicates expression from the reverse strand. X axis shows the time points (hours after administration of PMA; color code as shown in Figure 2).
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THP-1 line in which only a subset of cells responds to PMA.
They emphasized the role of AP1 transcription factors in the
formation of chromatin loops between distal enhancers and
macrophage-specific promoters, a conclusion that is supported
by the MARA analysis herein.
One of the cellular systems analyzed in FANTOM5, in which
there was a similar extensive change in gene expression, was
the activation of human monocyte-derived macrophages by
bacterial lipopolysaccharide (LPS) (Baillie et al., 2017). Network-
based analysis of that response identified waves of transiently
induced promoters/transcripts extending across the entire time
course up to 72 h. Each cluster of LPS-induced or repressed
transcripts contained both candidate feedback repressors of the
previous transcriptional cluster and transcription factors and
autocrine growth factors that contributed to the regulation
of subsequent clusters. The same pattern of transient waves
of inducible transcripts is evident in this PMA time course
in the high differentiation THP-1 cell line. For example, in
the network analysis (Supplementary Table S1), Cluster020
contains immediate early transcription factors as well as feedback
regulators such as ZFP36, which encodes an enzyme that
degrades unstable AU-rich mRNAs. The related gene, ZFP36L1,
was even more highly induced by PMA, peaking after 2–4 h
and remaining elevated. Over-expression of ZFP36L1 was shown
to positively-regulate differentiation in THP-1 cells. This was
attributed to degradation of CDK6 mRNA (Chen et al., 2015), but
this transcript was actually induced by PMA.
Cell cycle arrest in THP-1 cells probably involves multiple
mechanisms. THP-1 cells were reported to lack functional TP53
and indeed TP53 mRNA was low in THP-1 cells in the FANTOM
4 and FANTOM5 data (Suzuki et al., 2009; Forrest et al., 2014). In
the current study, TP53 mRNA was readily detectable in multiple
replicates and formed part of Cluster001. Consistent with
functional expression of TP53, PMA was previously shown to
induce the TP53-responsive cell cycle regulator p21WAF1/CIP1
(encoded by CDKN1A). Induction of both CDKN1A mRNA and
protein in published studies was detected after 24 hrs of PMA
treatment (Traore et al., 2005). Our study shows that induction of
CDKN1A by PMA is a much earlier event and provides insights
into the mechanism. Transcriptional activation of CDKN1A in
these cells has been linked to GC-rich binding sites for SP1 in the
proximal promoter (Traore et al., 2005; Pivoriunas et al., 2007).
CDKN1A has also been implicated in cell cycle arrest in response
to PMA in U937 myeloid leukemia cells (Vrana et al., 1998).
CDKN1A formed part of Cluster012, and was already strongly
induced 1 h after PMA addition, well in advance of cell cycle
blockade and consistent with the existence of a poised initiation
complex at the CDKN1A promoter (Espinosa et al., 2003). The
FANTOM5 data reveal the presence of regulated enhancers both
upstream and downstream of the CDKN1A promoter that were
also implicated in other human cell types (Espinosa et al., 2003).
SGK1 is another TP53 target gene (You et al., 2004) that was
also immediately and massively induced by PMA. Meta-analysis
of many large datasets identified only a limited set of consensus
TP53-dependent genes (Fischer, 2017). Amongst the most highly
validated targets, GDF15, PLK2, PLK3, BTG2, SESN1, and SESN2
(each of which can contribute to cell cycle arrest; Fischer, 2017;
Yuniati et al., 2019) were also induced rapidly during the THP-
1 time course of differentiation presented here and most likely
also controlled by poised promoters, whereas BAX, GADD45A,
MDM2, RRM2B, and SUSD6 were constitutively expressed.
Accordingly, it is unlikely that CDKN1A induction provides
the sole mechanism of cell cycle inhibition in PMA-stimulated
THP-1 cells. The expression of retinoblastoma (RB1), itself a
tumor suppressor gene (Dyson, 2016), and associated with G2/M
cell cycle arrest (Stark and Taylor, 2004) was rapidly induced
from two separate promoters by PMA. The set of inducible
genes in Cluster012 also contains ABL2 which suppresses
FLT3-induced proliferation (Kazi et al., 2017) and the tumor
suppressor gene DOCK4 (Sundaravel et al., 2015). Cluster003,
which peaks transiently around 6 h, contains transcripts encoding
cycle-dependent kinases encoded by CDK19 and CDK20 which
have complex functions in cell cycle regulation (reviewed in
Malumbres, 2014). By association, proteins encoded by other
transcripts within these clusters could also contribute to cell
cycle arrest. Amongst the most highly induced transcripts in
Cluster001 are candidate regulators of proliferation including the
MAP kinase inhibitor DUSP1 and GADD45G, which can drive
growth arrest and differentiation in hematopoietic stem cells
(Thalheimer et al., 2014).
The first detected response to PMA, as in other cellular state
transitions, was the induction of immediate early genes. In each
case, the mean gene expression increased to a peak within 1–2 h;
the patterns differed depending upon how rapidly the expression
decayed. As noted in the results, many IEG encode transcription
factors. One key immediate early gene that is specific to myeloid
lineages is MAFB. MAFB can drive monocyte commitment
when transduced into progenitor cells (Gemelli et al., 2006).
In the FANTOM 5 dataset, MAFB mRNA was most highly
expressed in monocytes and macrophages and induced in the
transition from committed granulocyte-macrophage progenitors
(Joshi et al., 2015). In the current study, MAFB was an IEG,
maximally up-regulated after 2 h and sustained thereafter. MAFB
mRNA and protein were reportedly also up-regulated in THP-
1 cells in response to a different differentiation signal, ATRA,
in combination with tumor necrosis factor (Zhang et al., 2012).
Given the rapidity of induction in our study, and the fact that
the MAFB locus is in open chromatin in THP-1 cells (Suzuki
et al., 2009; Phanstiel et al., 2017), transcriptional activation of
MAFB most likely involves a poised initiation complex. Zhang
et al. (2012) predicted target genes for MAFB based upon the
presence of MAF-response elements (MARE) in their promoters.
The MARE contains a consensus AP1 element and is partly
captured in our MARA analysis. The majority of the 64 putative
MAFB target genes (including AIM2, CCL2, LPXN, PRDM1,
SLC15A3, SPOCK1) were also progressively induced in our
study. However, although knockdown of MAFB compromised
expression of target genes such as PRDM1 and SPOCK1, it did
not prevent differentiation (Zhang et al., 2012).
Several other proteins encoded by IEG, notably JUN and
EGR2, also have specific functions in macrophage differentiation
(Rojo et al., 2017). NR4A1 is required specifically for the
maturation of blood monocytes to form the non-classical (in
mice, Ly6C−, in humans CD16++) subset (Thomas et al., 2016).
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Deletion of part of an enhancer in the mouse Nr4a1 locus
selectively ablated expression in monocytes (Thomas et al., 2016).
The FANTOM5 data reveal multiple upstream enhancers within
NR4A1 and the present THP-1 time course reveals at least two
regions of inducible bidirectional promoter activity.
Whereas there are numerous DNA-modifying transcription
factors up- and down-regulated across the time course of
differentiation, few regulated transcripts encoding chromatin
modifying enzymes were identified that could contribute to the
large-scale chromatin looping reported by Phanstiel et al. (2017).
The exception is KDM6B (also known as JMJD3), which was
almost undetectable in unstimulated cells and rapidly induced
alongside IEG transcription factors. In mice, KDM6B is required
for normal macrophage differentiation (Satoh et al., 2010).
Consistent with the induction during monocytic differentiation
in THP-1 cells, KDM6B was highly expressed in human
monocytes and induced further with adhesion (Forrest et al.,
2014). KDM6B is also recruited to TP53-dependent promoters in
many other cell types, so likely contributes also to growth arrest
(Williams et al., 2014).
The large set of transcripts within Cluster001 that was
progressively up-regulated across the time course of THP-1
differentiation provides a rich resource for the identification
of novel genes that are involved in cell cycle arrest on the
one hand and macrophage differentiation on the other. Their
inferred function is implied by stringent coregulation with many
genes of known function including macrophage differentiation
markers such as CD14, CD163, CSF1R, ITGAM, and MERTK and
by cross-comparison with primary cells [stem cells, committed
progenitors, monocytes and monocyte-derived macrophages in
the FANTOM5 data (Joshi et al., 2015)]. Cluster001 largely
overlaps with TF-Cluster04 (Supplementary Table S5) which
contains 47 transcription factors that likely contribute to the
terminal differentiation process. Of these candidate regulators,
the FANTOM5 data indicate that all but 3 (SHOX2, JRKL,
SOX4) are expressed in human monocytes or monocyte-derived
macrophages from the same transcription start sites. Amongst
the potential novel regulators, KLF6 has been implicated in
mouse macrophage polarization (Kim et al., 2020) but has not
previously been studied in human monocytes. Consistent with
late up-regulation in THP-1 cells, in the FANTOM5 data, KLF6
was highly expressed by monocytes and further up-regulated in
response to adhesion. Induction of KLF6 in THP-1 cells was
associated with activation of a cluster of enhancers detected
by bidirectional transcription initiation 20–50 kb upstream
that overlap monocyte-enriched enhancers detected in the
FANTOM5 data.
CAGE data also enables analysis of the precise transcription
start site used in the cell line compared to primary cells.
For example, as shown in Figure 6, TPRG1 (TP63-regulated
gene 1) was highly induced in parallel with BCL6. BCL6 is
highly expressed by human monocytes (Forrest et al., 2014).
The original description of the mouse gene Tprg1 noted
the location immediately upstream of Trp63 and described
expression specifically in the skin and down-regulation following
a Trp63 knockdown (Antonini et al., 2008). This region on
mouse chromosome 16 is syntenic with the region of the
human TPRG1 gene on chromosome 3. The TPRG1 protein
function is unknown. In the FANTOM5 data, TP63 is expressed
specifically in epithelial cells from multiple locations, but it was
barely detectable in baseline THP-1 cells. By contrast its role in
developmental regulation in the mouse (Antonini et al., 2008),
TPRG1 expression was not correlated with TP63 in the human
transcriptome (Forrest et al., 2014). It was most highly expressed
in adherent monocytes and monocyte-derived macrophages. Like
many human genes (Forrest et al., 2014), TPRG1 has multiple
tissue-specific promoters and THP-1 and monocytes share the
use of the most distal transcription start site generating a
unique non-coding 5′ exon. Similarly, FRMD4B was highlighted
as a transcript induced in parallel with MITF and likely
sharing enhancers. The parallel induction of these neighboring
genes was also observed in the generation of monocyte-derived
macrophages in response to CSF1 in the FANTOM5 data.
Like primary human monocytes and macrophages, THP-1
cells initiated transcription of MITF primarily from the most
5′ of at least 6 tissue-specific promoters. FRMD4B also has
multiple transcription starts sites and THP-1 and monocyte-
derived macrophages each initiate transcription from the most
5′ location. The only previous functional analysis of FRMD4B
protein (also known as GRSP1) described an interaction with
GRP1 (the product of CYTH3), a protein involved in regulation
of cell adhesion (Klarlund et al., 2001). One other example
of novel co-regulated genes is the ADCY8/ASAP1 locus on
chromosome 8. Both transcripts were rapidly induced by PMA
and there was extensive, inducible bidirectional transcription
initiation between the two genes, as well as within and
upstream of ADCY8 to the EFR3A gene, corresponding also
to FANTOM5 enhancers. ADCY8 encodes a calcium-sensitive
adenylate cyclase that has previously been shown to have
brain-specific neuronal functions (Masada et al., 2009) and the
brain-specific expression is confirmed in the FANTOM5 data.
ASAP1 encodes ARFGAP with SH3 domain, ankyrin repeat and
PH domain 1. This transcript is also a differentiation marker
in primary human cells; up-regulated in monocyte-derived
macrophages compared to blood monocytes in the FANTOM5
data. Like FRMD4B the ASAP1 protein product is likely involved
in cytoskeletal function in the development of adhesion (Liu et al.,
2002).
Conversely, in parallel with the loss of cell cycle-associated
transcription, the set of transcripts that is down-regulated
progressively in response to PMA includes genes that are specific
to monocytes and repressed upon macrophage differentiation.
One such gene is IRF8. IRF8 mutations in humans are
associated with monocyte deficiency (Crosslin et al., 2013). Other
monocyte-specific transcripts down-regulated by PMA include
the chemokine receptor, CCR2, the receptor for granulocyte
colony-stimulating factor (CSF3R), the tetraspanin MS4A3
(recently identified as a marker of monocytic progenitors; Liu
et al., 2019), P selectin ligand (SELPLG), surface markers (e.g.,
FCGR2A, CD38, CD302, CD320, GPR160) and S100A8/S100A9,
encoding the cytoplasmic calgranulin complex. MS4A3 is
expressed by committed human myeloid progenitors and down-
regulated in monocytes (Forrest et al., 2014). CSF3R, CCR2,
CD302, and S100A8/9 are amongst the large set of genes
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down-regulated during differentiation of macrophages from
blood monocytes (Baillie et al., 2017).
CONCLUSION
This study describes a detailed time course of growth arrest
and differentiation of the AML line, THP-1. Whereas these
processes are commonly portrayed as linear sequences with
a beginning and an end point, the time course reveals a
sequential cascade of transient changes in gene expression.
Even at 96 h post-stimulation, there are macrophage-associated
genes that appear to be increasing their expression (such as
CD14), most likely still responding to signals from CSF1R and
adhesion to the substratum. In mixed population of monocyte-
macrophages in tissues, differentiating asynchronously, this
sequential cascade might be (mis)interpreted as evidence of
the existence of distinct monocyte subpopulations. Hundreds of
signaling molecules, transcription factors and feedback regulators
are involved. The analysis reveals many novel inducible genes
(e.g., TPRG1, FRMD4B) for which there is currently no functional
annotation. THP-1 has been studied as an archetype of the
subset of AML that can respond to differentiation therapy
(Tagliafico et al., 2006). A detailed understanding of the process of
differentiation and growth arrest may highlight new therapeutic
targets and opportunities.
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